(Q40882221)

24 September 2017

title

Analyzing predictive models following definitive radiotherapy for prostate carcinoma (English)

1 reference

Adaptive radiation therapy

24 September 2017

main subject

0 references

author name string

Movsas B

1

1 reference

24 September 2017

Hanlon AL

2

1 reference

24 September 2017

Teshima T

3

1 reference

24 September 2017

Hanks GE

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

24 September 2017

1 reference

24 September 2017

volume

80

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

1093-1102

1 reference

An enhanced prognostic system for clinically localized carcinoma of the prostate

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Relationship between prostatic epithelial volume and serum prostate-specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1093%3A%3AAID-CNCR12%3E3.0.CO%3B2-3

10.1002/(SICI)1097-0142(19970915)80:6<1093::AID-CNCR12>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference